CRDF logo

Cardiff Oncology (CRDF)

Profile

Full Name

Cardiff Oncology, Inc.

Ticker Symbol

CRDF

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 27, 2004

Indexes

Not included

Website

http://www.cardiffoncology.com

Employees

32

Key Details

Price

$2.84(+1.02%)

Market cap

$188.85M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$683.00K(+39.96% YoY)

Annual EPS

-$0.95(-2.15% YoY)

PE ratio

-

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.84
CRDF price is $2.84

30-Day Relative Volume

1.41
CRDF 30-day relative volume is 1.41

Price Performance

Price Today change

+1.02%
CRDF price is up +1.02% today

Price YTD change

-34.59%
CRDF price is down -34.59% since January 1st

Price 1-year change

-36.92%
CRDF price is down -36.92% year-on-year

Price 3-year change

+46.33%
CRDF price is up +46.33% over the past 3 years

Price Range

Price All-time high

$2030.40
CRDF price is currently -99.86% below its historical high of $2030.40

Price 3-year low

$0.94
CRDF price is currently +202.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$188.85M
CRDF market capitalization is $188.85 million

Market cap 3-year change

+124.78%
CRDF market capitalization is up +124.78% over the past 3 years

Market cap All-time high

$872.87M
CRDF market capitalization is currently -78.36% below its historical high of $872.87 million

Market cap sector rank

56.66%
CRDF market capitalization is higher than 56.66% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+48.79%
CRDF shares outstanding is up +48.79% year-on-year

Shares Outstanding 3-Year Change

+53.61%
CRDF shares outstanding is up +53.61% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.29
CRDF beta is 1.29

200-day SMA

$3.11
CRDF price is currently -8.64% below its 200-day simple moving average

50-day SMA

$3.75
CRDF price is currently -24.29% below its 50-day simple moving average

RSI

40.66
CRDF 14-day relative strength index is 40.66

Volume

1.41
CRDF 30-day relative volume is 1.41

ATR

$0.26
CRDF average true range is $0.26

10-day Historical Volatility

103.46%
CRDF 10-day historical volatility is 103.46%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$683.00K
CRDF annual revenue is $683.00 thousand

Revenue Analysts estimate

$342.86K
CRDF annual revenue is currently +99.21% higher than the consensus analysts' forecast

Revenue 1-year change

+39.96%
CRDF annual revenue is up +39.96% year-on-year

Revenue Sector rank

11.09%
CRDF annual revenue is higher than 11.09% of companies in Healthcare sector

EPS

EPS

-$0.95
CRDF annual earnings per share is -$0.95

EPS Analysts estimate

-$0.82
CRDF annual earnings per share is currently +16.14% higher than the consensus analysts' forecast

EPS 1-year change

-2.15%
CRDF annual earnings per share is down -2.15% year-on-year

EPS Sector rank

57.69%
CRDF annual earnings per share is higher than 57.69% of companies in Healthcare sector

Profit

Gross profit

-
CRDF annual gross profit value is unknown

Gross margin

-
CRDF annual gross profit margin value is unknown

Operating profit

-$48.65M
CRDF annual operating income is -$48.65 million

Operating margin

-7123.13%
CRDF annual operating profit margin is -7123.13%

Net income

-$45.43M
CRDF annual net profit is -$45.43 million

Net margin

-6651.68%
CRDF annual net profit margin is -6651.68%

Expenses

Total expenses

$49.33M
CRDF annual total expenses is $49.33 million

Operating expenses

$49.33M
CRDF annual total operating expenses is $49.33 million

Cost of goods sold

-
CRDF annual cost of goods sold value is unknown

Selling, general & administrative expenses

$12.48M
CRDF annual SGA is $12.48 million

Depreciation and amortization

$404.00K
CRDF annual depreciation & amortization is $404.00 thousand

Interest expense

-
CRDF annual interest expense value is unknown

Income tax

-
CRDF annual income tax value is unknown

EBIT & EBITDA

EBIT

-$48.65M
CRDF annual earnings before interest & taxes is -$48.65 million

EBITDA

-$48.25M
CRDF annual EBITDA is -$48.25 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$97.19M
CRDF annual total assets is $97.19 million

Non current assets

$2.14M
CRDF annual long term assets is $2.14 million

Current assets

$95.05M
CRDF annual total current assets is $95.05 million

Cash and cash equivalents

$51.47M
CRDF annual cash & cash equivalents is $51.47 million

Accounts receivable

$773.00K
CRDF annual accounts receivable is $773.00 thousand

Inventory

-
CRDF annual inventory value is unknown

Liabilities

Total liabilities

$14.24M
CRDF annual total liabilities is $14.24 million

Long term liabilities

$813.00K
CRDF annual total long term liabilities is $813.00 thousand

Current liabilities

$13.43M
CRDF annual total current liabilities is $13.43 million

Accounts payable

$4.82M
CRDF annual accounts payable is $4.82 million

Debt

Total debt

$1.52M
CRDF annual total debt is $1.52 million

Total debt 1-year change

-29.13%
CRDF annual total debt is down -29.13% year-on-year

Long term debt

$813.00K
CRDF annual long term debt is $813.00 thousand

Short term debt

$710.00K
CRDF annual short term debt is $710.00 thousand

Equity & Capital

Shareholders equity

$82.95M
CRDF annual stockholders equity is $82.95 million

Book value

$82.95M
CRDF annual book value is $82.95 million

Retained earnings

-$384.18M
CRDF annual retained earnings is -$384.18 million

Working capital

$81.63M
CRDF annual working capital is $81.63 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$37.69M
CRDF annual cash flow from operations is -$37.69 million

Cash from operations 1-year change

-22.04%
CRDF annual cash flow from operations is down -22.04% year-on-year

Cash from investing

$13.73M
CRDF annual cash flow from investing activities is $13.73 million

Cash from investing 1-year change

-62.07%
CRDF annual cash flow from investing activities is down -62.07% year-on-year

Cash from financing

$53.78M
CRDF annual cash flow from financing activities is $53.78 million

Cash from financing 1-year change

+100%
CRDF annual cash flow from financing activities is up +100% year-on-year

CAPEX

CAPEX

$80.00K
CRDF annual capital expenditures is $80.00 thousand

CAPEX 1-year change

-86.25%
CRDF annual capital expenditures is down -86.25% year-on-year

Free Cash Flow

Free cash flow

-$37.77M
CRDF annual free cash flow is -$37.77 million

Free cash flow 1-year change

-20.03%
CRDF annual free cash flow is down -20.03% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CRDF annual gross profit margin value is unknown

Operating margin

-7123.13%
CRDF annual operating profit margin is -7123.13%

Net margin

-6651.68%
CRDF annual net profit margin is -6651.68%

ROA & ROE

ROA

-50.81%
CRDF annual return on assets is -50.81%

ROE

-59.51%
CRDF annual return on equity is -59.51%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CRDF price to earnings ratio value is unknown

PE ratio Sector rank

-
CRDF price to earnings ratio is unknown

PB Ratio

PB ratio

2.28
CRDF price to book ratio is 2.28

PB ratio Sector rank

66.31%
CRDF price to book ratio is higher than 66.31% of companies in Healthcare sector

PS Ratio

PS ratio

276.10
CRDF price to sales ratio is 276.10

PS ratio Sector rank

96.79%
CRDF price to sales ratio is higher than 96.79% of companies in Healthcare sector

Enterprise value

Enterprise value

$138.90M
CRDF enterprise value is $138.90 million

Enterprise value Sector rank

53.59%
CRDF enterprise value is higher than 53.59% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.88
CRDF EV/EBITDA is -2.88

EV/EBITDA Sector rank

26.43%
CRDF EV/EBITDA is higher than 26.43% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

7.08
CRDF annual current ratio is 7.08

Quick ratio

-
CRDF annual quick ratio value is unknown

Leverage

Debt to equity

0.00
CRDF annual debt to equity ratio is 0.00

Interest coverage ratio

-
CRDF annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CRDF piotroski f-score value is unknown

Altman Z-Score

1.79
CRDF altman z-score is 1.79

Analyst ratings

Recent major analysts updates

Feb 28, 25 HC Wainwright & Co.
Buy
Dec 13, 24 Piper Sandler
Overweight
Nov 8, 24 HC Wainwright & Co.
Buy
Sep 6, 24 Craig-Hallum
Buy
May 6, 24 HC Wainwright & Co.
Buy
Mar 6, 24 HC Wainwright & Co.
Buy
Mar 1, 24 Piper Sandler
Overweight
Aug 11, 23 HC Wainwright & Co.
Buy
Aug 8, 23 HC Wainwright & Co.
Buy
May 9, 23 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

TVGN logo
Tevogen Bio Holdings (TVGN)
SOPH logo
SOPHiA GENETICS SA (SOPH)
GOSS logo
Gossamer Bio (GOSS)
CGC logo
Canopy Growth (CGC)
ESPR logo
Esperion Therapeutics (ESPR)
MDWD logo
MediWound (MDWD)
LUNG logo
Pulmonx (LUNG)
OCGN logo
Ocugen (OCGN)
ANIK logo
Anika Therapeutics (ANIK)
  • What is the ticker symbol for Cardiff Oncology?
  • Does Cardiff Oncology pay dividends?
  • What sector is Cardiff Oncology in?
  • What industry is Cardiff Oncology in?
  • What country is Cardiff Oncology based in?
  • When did Cardiff Oncology go public?
  • Is Cardiff Oncology in the S&P 500?
  • Is Cardiff Oncology in the NASDAQ 100?
  • Is Cardiff Oncology in the Dow Jones?
  • When was Cardiff Oncology's last earnings report?
  • When does Cardiff Oncology report earnings?
  • Should I buy Cardiff Oncology stock now?

What is the ticker symbol for Cardiff Oncology?

The ticker symbol for Cardiff Oncology is NASDAQ:CRDF

Does Cardiff Oncology pay dividends?

No, Cardiff Oncology does not pay dividends

What sector is Cardiff Oncology in?

Cardiff Oncology is in the Healthcare sector

What industry is Cardiff Oncology in?

Cardiff Oncology is in the Biotechnology industry

What country is Cardiff Oncology based in?

Cardiff Oncology is headquartered in United States

When did Cardiff Oncology go public?

Cardiff Oncology's initial public offering (IPO) was on July 27, 2004

Is Cardiff Oncology in the S&P 500?

No, Cardiff Oncology is not included in the S&P 500 index

Is Cardiff Oncology in the NASDAQ 100?

No, Cardiff Oncology is not included in the NASDAQ 100 index

Is Cardiff Oncology in the Dow Jones?

No, Cardiff Oncology is not included in the Dow Jones index

When was Cardiff Oncology's last earnings report?

Cardiff Oncology's most recent earnings report was on Feb 27, 2025

When does Cardiff Oncology report earnings?

The next expected earnings date for Cardiff Oncology is May 2, 2025

Should I buy Cardiff Oncology stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page